DOCS.L LSE
Dr. Martens plc
1W: -1.8%
1M: -6.5%
3M: -8.6%
YTD: -3.1%
1Y: -27.0%
3Y: -55.6%
5Y: -81.9%
£66.60 ($0.88)
-0.50 (-0.75%)
Weekly Expected Move ±4.6%
£60
£64
£67
£70
£73
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$765M
-2.9% ▼
5Y CAGR: -0.2%
Gross Profit
$506M
-1.1% ▼
5Y CAGR: +1.5%
Operating Income
$73M
+30.8% ▲
5Y CAGR: -8.2%
Net Income
$24M
+428.9% ▲
5Y CAGR: -7.3%
EPS (Diluted)
$0.02
+386.0% ▲
5Y CAGR: -6.9%
EBITDA
$142M
+28.6% ▲
5Y CAGR: -0.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $908M | $1.0B | $877M | $788M | $765M |
| YoY Growth | +17.5% | +10.1% | -12.3% | -10.2% | -2.9% |
| Cost of Revenue | $330M | $382M | $302M | $276M | $259M |
| Gross Profit | $579M | $618M | $575M | $512M | $506M |
| Gross Margin | 63.7% | 61.8% | 65.6% | 65.0% | 66.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $309M | $373M | $449M | $100K | -$700K |
| Operating Expenses | $353M | $427M | $449M | $456M | $366M |
| Operating Income | $228M | $181M | $126M | $56M | $73M |
| Operating Margin | 25.1% | 18.1% | 14.4% | 7.1% | 9.6% |
| Interest Expense | $14M | $18M | $31M | $29M | $28M |
| Income Before Tax | $214M | $159M | $93M | $9M | $33M |
| Tax Expense | $33M | $30M | $24M | $4M | $9M |
| Net Income | $181M | $129M | $69M | $4M | $24M |
| Net Margin | 19.9% | 12.9% | 7.9% | 0.6% | 3.1% |
| EPS (Diluted) | $0.18 | $0.13 | $0.07 | $0.01 | $0.02 |
| EBITDA | $265M | $235M | $196M | $110M | $142M |
| Shares Outstanding | 1.00B | 1.00B | 986M | 974M | 980M |